Cointime

StageZero Life Sciences

company

About

StageZero Life Sciences is a biotech company developing and commercializing blood-based diagnostic tests for early disease detection.

  • Richmond Hill,Ontario,Canada
  • 1 - 10

Highlights

Stock Symbol
otcqb:SZLSF
Total Funding Amount
$20.72M $4.20M
Funding Rounds
11
Investors
1
Acquisition
1
Employee Profiles
6

Details

Last Funding Type
Post-IPO Equity
Last Funding Money Raised
$208K
Industries
Biotechnology,Health Care,Health Diagnostics
Founded date
Jan 1, 1998
Number Of Employee
1 - 10
Operating Status
Active
Stock Symbol
otcqb:SZLSF
Legal Name
StageZero Life Sciences Ltd
Also Known As
GeneNews

StageZero Life Sciences is a biotech company developing and commercializing blood-based diagnostic tests for early disease detection. The company next-generation test, Aristotle, is a multi-cancer panel for simultaneously screening for 10 cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle is built on its proprietary mRNA technology platform, which was validated on 10,000 patients and used to develop the first liquid biopsy for Colorectal Cancer.

StageZero Life Sciences was founded in 1998 and is based in Richmond Hill, Ontario, Canada.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
11
$20.72M $4.20M
StageZero Life Sciences has raised a total of $20.72M $4.20M in funding over 2 rounds. Their latest funding was raised on Nov 23, 2021 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 23, 2021 Post-IPO Equity $4.20M — — — Detail
Jul 12, 2021 IPO — — — — Detail
Feb 1, 2019 Post-IPO Equity $208K 1 — — Detail
Jul 31, 2017 Post-IPO Equity $245.55K — — — Detail
Apr 14, 2016 Post-IPO Equity $370.43K — — — Detail
Show More

Investors

Number of Lead Investors
Number of Investors
—
1
StageZero Life Sciences is funded by 1 investors. Keiretsu Forum are the most recent investors.
Investor Name Lead Investor Funding Round
Keiretsu Forum — Post-IPO Equity

Employee Profiles

Number of Employee Profiles
6
StageZero Life Sciences has 6 current employee profiles, including Board member Heiner Dreismann
Heiner Dreismann
Board member
Choong-Chin Liew
Executive
Leslie Auld
Executive
Matthew J. Pietras
Executive
Show More

Acquisition

StageZero Life Sciences has acquired 1 organizations. Their most recent acquisition was Health Clinics-clinics Operations on Aug 16, 2021. They acquired Health Clinics-clinics Operations for 0.

Date Company Name
Industry Acquisition Type Price
Aug 16, 2021 Health Clinics-clinics Operations
Health Care acquisition — Detail
Cointime
เนื้อหา
บริษัท